Rise Nano Optics plans C$5M private placement to fund lens tech

Rise Nano Optics Ltd. (CSE: EYE) (OTCQB: RNOLF) (FSE: U9Y) announced a proposed non-brokered private placement of up to 10,000,000 units at C$0.50 per unit, targeting gross proceeds of up to C$5,000,000, with a minimum financing amount of C$3,000,000.

Each unit consists of one common share and one warrant. Each warrant entitles the holder to acquire one additional share at C$1.00 for 24 months following the applicable closing date. The offering is expected to close on or about December 15, 2026, subject to standard conditions including board approval and Canadian Securities Exchange requirements.

The company intends to use the proceeds to advance commercialization of its SpectraGuard lens technology, expand optical laboratory partnerships, support manufacturing capabilities, pursue potential acquisitions, and fund general working capital.

The announcement accompanies several recent developments disclosed by the company, including FDA Class 1 Medical Device Classification and Registration for SpectraGuard, partnerships with Sierra Optical Lab and Sportifeye Optics for lens production, and a clinical channel partnership with LI Opticians through which patient sales have commenced.

Rise also noted its listing on the CSE in March 2026, followed by additional listings on the OTCQB and the Frankfurt Stock Exchange.

"With SpectraGuard now entering commercial distribution through our optical laboratory partners, our focus is on accelerating adoption, expanding production capabilities, and building the infrastructure needed to support long-term growth," said Inas Said, Chief Executive Officer of Rise Nano Optics.

The securities will not be registered under the U.S. Securities Act of 1933 and may not be offered or sold in the United States absent an applicable exemption. The company has not announced finder's fees in connection with the offering.

You May Also Be Interested In

• Kotak Upgrades Indusind Bank Ltd (IIB:IN) to Reduce (3)
• Jefferies Upgrades Dr. Reddy\'s Laboratories Ltd. (DRRD:IN) (RDY) to Hold
• Dr. Reddy\'s Laboratories Ltd. (DRRD:IN) (RDY) PT Raised to INR1,235 at Axis Capital Limited